Mergers & Acquisitions ·
Tempus AI, Inc. entered into a Merger Agreement on July 20, 2026, to acquire Personalis, Inc. through a two-step…
TEMTempus AI, Inc.
Tempus AI, Inc. entered into a Merger Agreement on July 20, 2026, to acquire Personalis, Inc. through a two-step merger involving its subsidiaries. The transaction consideration includes Tempus Class A Common Stock based on a variable exchange ratio determined by Tempus's stock price, with an option for Tempus to pay cash for up to 50% of the outstanding Personalis shares at $16.25 per share. Tempus AI, Inc. operates in the healthcare technology and data-driven precision medicine industry through its AI-driven platform.